Abstract

Background: An extremely common, chronic, and frequently disabling condition of the gutbrain connection, is irritable bowel syndrome (IBS). It is characterised by recurring stomach pain and changes in bowel habits. Grahani is the seat of Jatharagni and Grahani Dosha is one among the Mahagadas. Grahani is a disease of great clinical relevance in today's modern era because of its direct link with the improper food habits and stressful lifestyle of the present time. Vitiation of Agni affects the digestion process and vitiates proper formation of further dhathus, so one should give importance to the management of Agni.

Aim: Ayurveda described various treatment modalities for the management of Grahani Roga. In this article we tried to summarized the effect of Takra (buttermilk) in Grahani Roga with the help of Ayurvedic principles and pharmacodynamics.

Methods and Materials: Various Ayurvedic texts like Charaka Samhita, Susruta Samhita, AstangHridya and relevant modern medical science books.

Conclusion: Shamana and Shodhana chikitsa modalities are adopted to treat Grahani but diet and lifestyle are the most important modalities to be followed to control or cure the condition. Takra is compared with Amrita because of its qualities. Acharya Vagbhata states that Takra does Srotoshodhana and helps the rasa to reach the srotas. Takra by its different gunas acts as tridosha shamaka, it is very helpful in the patients suffering from agni vikriti have different types of dosha dushti.

• 1.   Mishra S; Kushavaha HC, editor. Charak Samhita. Vol 2. 1st ed. Varanasi: Chaukhamba Orientalia; 2009. Chapter 15, Grahanichikitsaadhyaya; p. 394.
• 2.   Sharma PV; Trikamji Y, editor. Sushrutasamhita of Sushruta with the Commentary of Dalhanacharya. 4th ed. Varanasi: Chaukhamba Orientalia; 1980. Uttartantra, Chapter 40, Atisara Paratishedhaadhyaya; p. 710.
• 3.   Sharma PV; Paradkar HS, editor. Asthangahridaya of Vagbhata with the Commentaries of Arunadatta and Hemadri. Varanasi: Chaukhamba Surbharati Prakashan. Nidanastahna, Chapter 8, Atisaragrahanidosha Nidanam; p. 495-497.
• 4.   Rahman MM, et al. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol. 2017;23(37):6788-6801.
• 5.   Shastri AD, editor. Sushruta Samhita with Ayurveda Tattva Sandipika commentary. Reprint ed. Varanasi: Chaukhambha Sansthan; 2016. Uttara Tantra 40/167.
• 6.   Kushwaha H, editor. Charaka Samhita of Agnivesha with Ayurveda Dipika commentary of Chakrapanidatta. Vol 2. Varanasi: Chaukhambha Sansthan. Chikitsa Sthana 15/53.
• 7.   Kushwaha H, editor. Charaka Samhita of Agnivesha with Ayurveda Dipika commentary of Chakrapanidatta. Vol 2. Reprint ed. Varanasi: Chaukhambha Sansthan; 2011. Chikitsa Sthana 15/73-75.
• 8.   Tripati I, editor. Raja Nighantu with Dravyaguna Prakashika Hindi commentary. Varanasi: Krishnadas Academy. (Krishnadas Ayurveda series). Chikitsa Sthana 15/120-121.
• 9.   Kushwaha H, editor. Charaka Samhita of Agnivesha with Ayurveda Dipika commentary of Chakrapanidatta. Vol 2. Reprint ed. Varanasi: Chaukhambha Sansthan; 2011. Chikitsa Sthana 15/73-75.
• 10.   Nirgude R, Binorkar S, Parlikar G, Kirte M. Therapeutic and nutritional values of takra (buttermilk). Int Res J Pharm. 2013;4:29-31.
• 11.   Gille D. The health aspects of buttermilk components-A review. Posieux, Switzerland: Agroscope Liebefeld-Posieux Research Station ALP; 2011 Nov. (ALP Science No. 540).
• 12.   Laudman S. Health benefits of buttermilk. 2013.
• 13.   Utilization of buttermilk in the form of condensed and dried buttermilk. J Dairy Sci. 1923;6(1):1–12.
• 14.   Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol. 2009;296:G868–G875.
• 15.   McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil. 2010;22:1029–1035.

Data Sharing Statement

Funding